{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:14:58Z","timestamp":1794899698089,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunosuppression after kidney transplantation is mainly guided via plasma tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The plasma load of the non-pathogenic and highly prevalent torque teno virus (TTV) is associated with the immunosuppression of its host. Non-interventional studies suggest the use of TTV load to predict allograft rejection and infection. The primary objective of the current trial is to demonstrate the safety, tolerability and preliminary efficacy of TTV-guided immunosuppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>For this purpose, a randomised, controlled, interventional, two-arm, non-inferiority, patient- and assessor-blinded, investigator-driven phase II trial was designed. A total of 260 stable, low-immunological-risk adult recipients of a kidney graft with tacrolimus-based immunosuppression and TTV infection after month 3 post-transplantation will be recruited in 13 academic centres in six European countries. Subjects will be randomised in a 1:1 ratio (allocation concealment) to receive tacrolimus either guided by TTV load or according to the local centre standard for 9 months. The primary composite endpoint includes the occurrence of infections, biopsy-proven allograft rejection, graft loss, or death. The main secondary endpoints include estimated glomerular filtration rate, graft rejection detected by protocol biopsy at month 12 post-transplantation (including molecular microscopy), development of de novo donor-specific antibodies, health-related quality of life, and drug adherence. In parallel, a comprehensive biobank will be established including plasma, serum, urine and whole blood. The date of the first enrolment was August 2022 and the planned end is April 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The assessment of individual kidney transplant recipient immune function might enable clinicians to personalise immunosuppression, thereby reducing infection and rejection. Moreover, the trial might act as a proof of principle for TTV-guided immunosuppression and thus pave the way for broader clinical applications, including as guidance for immune modulators or disease-modifying agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>EU CT-Number: 2022-500024-30-00<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07216-0","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T11:19:41Z","timestamp":1679483981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT"],"prefix":"10.1186","volume":"24","author":[{"given":"Frederik","family":"Haupenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Rahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Gelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Herkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wolzt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Doberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Vossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Focosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Neuwirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Banas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Banas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Viklicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris I.","family":"Rotmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cejka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Molina","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rodriguez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0440-3053","authenticated-orcid":false,"given":"Gregor","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the TTVguideTX consortium partners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Melzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"del Alamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Beneyto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"issue":"10","key":"7216_CR1","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/ndt\/gfx365","volume":"33","author":"D Abramowicz","year":"2018","unstructured":"Abramowicz D, Oberbauer R, Heemann U, Viklicky O, Peruzzi L, Mariat C, et al. Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board. Nephrol Dial Transplant. 2018;33(10):1699\u2013707.","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"7216_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, van Gelder T, Asberg A, Haufroid V, Hesselink DA, Langman L, et al. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Ther Drug Monit. 2019;41(3):261\u2013307.","journal-title":"Ther Drug Monit."},{"issue":"5","key":"7216_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/ajt.12191","volume":"13","author":"R Bouamar","year":"2013","unstructured":"Bouamar R, Shuker N, Hesselink DA, Weimar W, Ekberg H, Kaplan B, et al. Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(dagger). Am J Transplant. 2013;13(5):1253\u201361.","journal-title":"Am J Transplant."},{"issue":"1","key":"7216_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1681\/ASN.2017010004","volume":"29","author":"M Naesens","year":"2018","unstructured":"Naesens M, Anglicheau D. Precision transplant medicine: biomarkers to the rescue. J Am Soc Nephrol. 2018;29(1):24\u201334.","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"7216_CR5","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/TP.0000000000001321","volume":"100","author":"D Anglicheau","year":"2016","unstructured":"Anglicheau D, Naesens M, Essig M, Gwinner W, Marquet P. Establishing biomarkers in transplant medicine: a critical review of current approaches. Transplantation. 2016;100(10):2024\u201338.","journal-title":"Transplantation."},{"issue":"12","key":"7216_CR6","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2215\/CJN.01790215","volume":"10","author":"PE Cippa","year":"2015","unstructured":"Cippa PE, Schiesser M, Ekberg H, van Gelder T, Mueller NJ, Cao CA, et al. Risk stratification for rejection and infection after kidney transplantation. Clin J Am Soc Nephrol. 2015;10(12):2213\u201320.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"9","key":"7216_CR7","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/cid\/cix1008","volume":"66","author":"M Mian","year":"2018","unstructured":"Mian M, Natori Y, Ferreira V, Selzner N, Husain S, Singer L, et al. Evaluation of a novel global immunity assay to predict infection in organ transplant recipients. Clin Infect Dis. 2018;66(9):1392\u20137.","journal-title":"Clin Infect Dis."},{"issue":"8","key":"7216_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/TP.0000000000000650","volume":"99","author":"M Ravaioli","year":"2015","unstructured":"Ravaioli M, Neri F, Lazzarotto T, Bertuzzo VR, Di Gioia P, Stacchini G, et al. Immunosuppression modifications based on an immune response assay: results of a randomized, controlled trial. Transplantation. 2015;99(8):1625\u201332.","journal-title":"Transplantation."},{"issue":"2","key":"7216_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1681\/ASN.2020050645","volume":"32","author":"T Ahlenstiel-Grunow","year":"2021","unstructured":"Ahlenstiel-Grunow T, Liu X, Schild R, Oh J, Taylan C, Weber LT, et al. Steering transplant immunosuppression by measuring virus-specific T cell levels: the randomized, controlled IVIST trial. J Am Soc Nephrol. 2021;32(2):502\u201316.","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"7216_CR10","first-page":"2081","volume":"20","author":"P Jaksch","year":"2022","unstructured":"Jaksch P, Gorzer I, Puchhammer-Stockl E, Bond G. Integrated immunologic monitoring in solid organ transplantation: the road towards torque teno virus-guided immunosuppression. Transplantation. 2022;20(8):2081\u201390.","journal-title":"Transplantation."},{"issue":"5","key":"7216_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.cell.2013.10.034","volume":"155","author":"I De Vlaminck","year":"2013","unstructured":"De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell. 2013;155(5):1178\u201387.","journal-title":"Cell."},{"issue":"2","key":"7216_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jmv.25488","volume":"94","author":"L Macera","year":"2022","unstructured":"Macera L, Spezia PG, Medici C, Rofi E, Del Re M, Focosi D, et al. Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence. J Med Virol. 2022;94(2):491\u20138.","journal-title":"J Med Virol."},{"issue":"2","key":"7216_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/TP.0000000000001455","volume":"101","author":"M Schiemann","year":"2017","unstructured":"Schiemann M, Puchhammer-Stockl E, Eskandary F, Kohlbeck P, Rasoul-Rockenschaub S, Heilos A, et al. Torque teno virus load-inverse association with antibody-mediated rejection after kidney transplantation. Transplantation. 2017;101(2):360\u20137.","journal-title":"Transplantation."},{"key":"7216_CR14","doi-asserted-by":"crossref","unstructured":"Doberer K, Schiemann M, Strassl R, Haupenthal F, Dermuth F, Gorzer I, et al. Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-a prospective observational trial. Am J Transplant. 2020.","DOI":"10.1093\/ndt\/gfaa142.P1624"},{"issue":"4","key":"7216_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ajt.15145","volume":"19","author":"M Fernandez-Ruiz","year":"2019","unstructured":"Fernandez-Ruiz M, Albert E, Gimenez E, Ruiz-Merlo T, Parra P, Lopez-Medrano F, et al. Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation. Am J Transplant. 2019;19(4):1139\u201349.","journal-title":"Am J Transplant"},{"issue":"12","key":"7216_CR16","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/infdis\/jiz039","volume":"219","author":"R Strassl","year":"2019","unstructured":"Strassl R, Doberer K, Rasoul-Rockenschaub S, Herkner H, Gorzer I, Klager JP, et al. Torque teno virus for risk stratification of acute biopsy-proven alloreactivity in kidney transplant recipients. J Infect Diseases. 2019;219(12):1934\u20139.","journal-title":"J Infect Diseases."},{"issue":"1","key":"7216_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jinf.2019.05.010","volume":"79","author":"M Solis","year":"2019","unstructured":"Solis M, Velay A, Gantner P, Bausson J, Filipputtu A, Freitag R, et al. Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. J Infect. 2019;79(1):56\u201360.","journal-title":"J Infect."},{"key":"7216_CR18","doi-asserted-by":"publisher","first-page":"104871","DOI":"10.1016\/j.jcv.2021.104871","volume":"140","author":"AL van Rijn","year":"2021","unstructured":"van Rijn AL, Wunderink HF, Sidorov IA, de Brouwer CS, Kroes AC, Putter H, et al. Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection. J Clin Virol. 2021;140:104871.","journal-title":"J Clin Virol."},{"issue":"9","key":"7216_CR19","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1097\/TP.0000000000003619","volume":"105","author":"K Doberer","year":"2021","unstructured":"Doberer K, Haupenthal F, Nackenhorst M, Bauernfeind F, Dermuth F, Eigenschink M, et al. Torque teno virus load is associated with subclinical alloreactivity in kidney transplant recipients: a prospective observational trial. Transplantation. 2021;105(9):2112\u20138.","journal-title":"Transplantation."},{"issue":"2","key":"7216_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/jcm9020440","volume":"9","author":"EJ Gore","year":"2020","unstructured":"Gore EJ, Gomes-Neto AW, Wang L, Bakker SJL, Niesters HGM, de Joode AAE, et al. Torquetenovirus serum load and long-term outcomes in renal transplant recipients. J Clin Med. 2020;9(2):440.","journal-title":"J Clin Med."},{"key":"7216_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jcv.2019.03.018","volume":"116","author":"L Handala","year":"2019","unstructured":"Handala L, Descamps V, Morel V, Castelain S, Francois C, Duverlie G, et al. No correlation between torque teno virus viral load and BK virus replication after kidney transplantation. J Clin Virol. 2019;116:4\u20136.","journal-title":"J Clin Virol."},{"issue":"2","key":"7216_CR22","doi-asserted-by":"publisher","first-page":"e13240","DOI":"10.1111\/tid.13240","volume":"22","author":"M Fernandez-Ruiz","year":"2020","unstructured":"Fernandez-Ruiz M, Albert E, Gimenez E, Rodriguez-Goncer I, Andres A, Navarro D, et al. Early kinetics of torque teno virus DNA load and BK polyomavirus viremia after kidney transplantation. Transplant Infect Disease. 2020;22(2):e13240.","journal-title":"Transplant Infect Disease"},{"issue":"1","key":"7216_CR23","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1038\/s41598-018-33909-7","volume":"8","author":"F Maggi","year":"2018","unstructured":"Maggi F, Focosi D, Statzu M, Bianco G, Costa C, Macera L, et al. Early post-transplant torquetenovirus viremia predicts cytomegalovirus reactivations in solid organ transplant recipients. Scientific Rep. 2018;8(1):15490.","journal-title":"Scientific Rep."},{"issue":"8","key":"7216_CR24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiy306","volume":"218","author":"R Strassl","year":"2018","unstructured":"Strassl R, Schiemann M, Doberer K, Gorzer I, Puchhammer-Stockl E, Eskandary F, et al. Quantification of torque teno virus viremia as a prospective biomarker for infectious disease in kidney allograft recipients. J Infect Dis. 2018;218(8):1191\u20139.","journal-title":"J Infect Dis."},{"issue":"1","key":"7216_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00467-020-04606-3","volume":"36","author":"P Uhl","year":"2021","unstructured":"Uhl P, Heilos A, Bond G, Meyer E, Bohm M, Puchhammer-Stockl E, et al. Torque teno viral load reflects immunosuppression in paediatric kidney-transplanted patients-a pilot study. Pediatr Nephrol. 2021;36(1):153\u201362.","journal-title":"Pediatr Nephrol."},{"key":"7216_CR26","doi-asserted-by":"publisher","first-page":"105348","DOI":"10.1016\/j.jcv.2022.105348","volume":"158","author":"I G\u00f6rzer","year":"2022","unstructured":"G\u00f6rzer I, Haupenthal F, Maggi F, Gelas F, Kulifaj D, Brossault J, et al. Validation of plasma torque teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation. J Clin Virol. 2022;158:105348.","journal-title":"J Clin Virol."},{"issue":"Pt 1","key":"7216_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1099\/vir.0.070094-0","volume":"96","author":"D Focosi","year":"2015","unstructured":"Focosi D, Macera L, Boggi U, Nelli LC, Maggi F. Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells. J Gen Virol. 2015;96(Pt 1):115\u20137.","journal-title":"J Gen Virol."},{"issue":"25","key":"7216_CR28","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357(25):2562\u201375.","journal-title":"N Engl J Med."},{"key":"7216_CR29","unstructured":"Kulifaj D, Niesters H, McCulloch E, Goerzer I, Bourgeois P, Barranger C, et al. Implementation of TTV R-GENE\u00ae to quantify torque tenovirus load in a randomized controlled trial assessing the value of TTV-guided immunosuppression post kidney transplantation. [poster presentation at the 24th congress of the European Society of Clinical Virology in Manchester]. In press 2022."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07216-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:13:17Z","timestamp":1761203597000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07216-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7216"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07216-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2337435\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"6 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved on 04.07.2022 via CTIS for all participating countries. Written informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as a potential competing interest concerning the present work: Fanny Gelas, and Philippe Bourgeois are employees of bioM\u00e9rieux.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"213"}}